Sign in →

Test Code FLNZ / FLNZ-M Olanzapine (Zyprexa)

Additional Codes

Software Test Codes
Label Text  FLNZ
EPIC LAB20561
Mayo Clinic Laboratories FLNZ

 

Reporting Name

Olanzapine (Zyprexa)

Performing Laboratory

Medtox Laboratories, Inc.

Specimen Type

Varies


Specimen Required


Submit only 1 of the following specimens:

 

Plasma

Draw blood in a green-top (sodium heparin) tube(s), plasma gel tube is not acceptable. Spin down and send 2 mL sodium heparin plasma refrigerated in a plastic vial.

 

Serum

Draw blood in a plain red-top tube(s), serum gel tube is not acceptable. Spin down and send 2 mL of serum refrigerated in a plastic vial.  


Specimen Minimum Volume

0.50 mL

Specimen Stability Information

Specimen Type Temperature Time
Varies Refrigerated (preferred) 14 days
  Frozen  180 days
  Ambient  72 hours

Reject Due To

Hemolysis NA
Lipemia NA
Icterus NA
Other NA
 

Reference Values

Reference Range:          10.0 – 80.0 ng/mL

 

Expected steady state concentrations in patients on recommended daily dosages:

            10 – 80.0 ng/mL

Plasma concentrations of olanzapine greater than 9.0 ng/mL have been associated with therapeutic effect.

 

Toxic range has not been established.

 

Day(s) Performed

Monday through Sunday

CPT Code Information

80299

LOINC Code Information

Test ID Test Order Name Order LOINC Value
FLNZ Olanzapine (Zyprexa) 12389-3

 

Result ID Test Result Name Result LOINC Value
Z1196 Olanzapine 12389-3

Report Available

7 to 11 days
NorDx Test Catalog Note:

Analytic time for send out tests is the time it will take to perform testing once it has arrived at the performing reference lab. Please add 1 to 2 days from time of collection to allow for receipt at NorDx central lab and shipment of specimen, add another day if specimen is collected on the day before a weekend or holiday.

Method Name

Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)

Secondary ID

91129

Test Classification

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.